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Introduction: Blood acidification by lactic acid infusion converts bicarbonate to CO2. This effect can be exploited to
increase the transmembrane PCO2 gradient of an extracorporeal membrane lung, resulting in a significant increase
of extracorporeal CO2 removal. Lactic acid, however, is an energetic substrate and its metabolism might increase
total body CO2 production (VCO2), limiting the potential beneficial effects of this technique. The aim of our study
was to compare VCO₂ during isocaloric infusion of lactic acid or glucose.
Methods: Six pigs (45 ± 5 kg) were sedated and mechanically ventilated. Estimated caloric needs were 2,300–2,400
Kcal/die (95 to 100 Kcal/h). A sequence of two steps lasting four hours each was performed: 1) Glucose, 97 kcal/h
were administered as 50% glucose solution, and 2) Lactic Acid, approximately 48.5 kcal/h were administered as lactic
acid and approximately 48.5 kcal/h as 50% glucose solution. This sequence was repeated three times with two-hour
intervals. Every hour VCO₂, arterial blood gases and lactate were measured. Blood glucose level was kept constant by
titrating an insulin infusion, ventilation was adjusted to maintain arterial PCO2 at 50 mmHg, a normal value for our
animal model.
Results: During Lactic Acid steps VCO2 increased less than 5% compared to the Glucose steps (282 vs. 269 ml/min,
P<0.05); blood glucose did not differ between the two groups (respectively 101 ± 12 vs. 103 ± 8 mg/dl). Arterial lactate
was always lower than 3 mmol/L. Arterial pH was lower during Lactic Acid steps (7.422 vs. 7.445, P<0.05).
Conclusions: Replacing 50% of the caloric input with lactic acid increased total CO2 production by less than 5% compared
to an equal caloric load provided entirely by a 50% glucose solution.Introduction
Partial extracorporeal CO2 removal (ECCO2R), initially in-
troduced in the late 1970s [1-5], allows ultra-protective
mechanical ventilation, and might help limit Ventilation-
Induced Lung Injury (VILI) in Acute Respiratory Distress
Syndrome (ARDS) patients [6]. Moreover, it may enable
awake hypercapnic patients [7,8] or patients awaiting lung
transplantation to avoid endotracheal intubation [7,9].
Despite major improvements in extracorporeal technology,* Correspondence: antonio.pesenti@unimib.it
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reproduction in any medium, provided the ormoderate/high extracorporeal blood flow rates (500 to
1,000 ml/minute) [10,11] are still required to remove a sig-
nificant fraction (for example, 50%) of the total CO2 pro-
duction of an adult patient. This implies the use of large
diameter vascular catheters and specific technical require-
ments that limit the application of the procedure. The rate
of CO2 removal is limited by the fact that most of the CO2
in blood (approximately, 90%) is present as bicarbonate ion
that cannot cross the artificial lung membrane, which is
permeable to gases but not to solutes and water. Acid infu-
sion shifts bicarbonate dissociation to the gaseous CO2Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Figure 1 Outline of the experimental setup. DF, dialyzer
hemofilter. Circles represent the withdrawal sites.
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sure gradient and thus increasing extracorporeal CO2
removal. Regional extracorporeal infusion of lactic acid
before the artificial lung has proved to effectively increase
the efficiency of an extracorporeal CO₂ removal system in
an experimental setting [12,13]. This technique may allow
the removal of more than 100 ml/minute of CO2 from an
extracorporeal blood flow as low as 250 ml/minute [14].
Such a low blood flow may be achieved with vascular ac-
cesses and technology similar to the ones used for con-
tinuous renal replacement therapy in the intensive care
unit. Lactic acid, however, is an energetic substrate and its
metabolism, producing CO₂, may potentially reduce the
clinical benefit of extracorporeal CO₂ removal [15-17].
The present study was designed to assess, in a swine
model, the impact of lactic acid infusion on whole
body CO₂ production compared to an isocaloric glu-
cose infusion.
Materials and methods
Experimental setting
Animal care and treatment were conducted in accord-
ance with the Institutional Guidelines for the Care and
Use of Laboratory Animals (University of Milan) and in
compliance with national laws and policies (D.L. n.116 G.U.,
suppl. 40, 18/02/1992; Circolare n.8, G.U., 14/07/1994),
under the supervision of the veterinarian responsible
for laboratory animal welfare. The protocol was ap-
proved by the University of Milan and MIUR (Minis-
tero dell’Istruzione, dell’Università e della Ricerca).
Six female Large White pigs (weight 44.9 ± 5 kg)
were initially sedated with an intramuscular injection
of medetomidine (Domitor® PFIZER ITALIA Srl (DIV.
VET.), Latina, Italy, 0.03 mg/kg) and tiletamine-zolazepam
(Zoletil® VIRBAC Srl, Milan, Italy, 4 mg/kg); after
catheterization of an ear vein, anesthesia was induced with
propofol (Propofol Kabi® Fresenius Kabi Italia S.r.l. Isola
della Scala, Verona, 2 to 2.5 mg/kg) to allow endotracheal
intubation and mechanical ventilation (Servo 900C,
Siemens-Elema AB, Sweden). Anesthesia was then
maintained with continuous intravascular infusion of
sodium thiopental (Pentothal Sodium® HOSPIRA SpA,
Liscate (MI), Italy, 10 to 25 mg/kg/h), fentanyl (Fentanest®
Pfizer Italia S.r.l., Latina, Italia, 50 to 200 mcg/h) and
rocuronium (Esmeron® MSD Italia S.r.l., Roma, Italia,
30 to 100 mg/h). A Foley urinary catheter (8 to 10 Fr)
was inserted and connected to a urine collection bag.
Before surgery antibiotic prophylaxis with ceftriaxone
(Fidato® Fidia Farmaceutici S.p.A., Abano Terme (PD),
Italia, 2 g) and gentamycin (Gentamicina Pensa® Pensa
Pharma S.p.A., Milano, Italia, 80 mg) was adminis-
tered. The right femoral artery and left internal jugular
vein were surgically cannulated for pressure monitor-
ing, blood gas analysis and drug infusion. Followingadministration of an unfractioned heparin bolus
(Epsoclar® Mayne Pharma Srl, Napoli, Italia, 200 U/kg),
pigs were connected to a veno-venous extracorporeal
circuit after surgical cannulation of the right external
jugular vein with a 14-Fr catheter (Medtronic, Minne-
apolis, MN, USA) for blood drainage and of the right
femoral vein with a 10 to 12-Fr cannula for reinfusion.
The extracorporeal circuit, required to infuse a concen-
trated (40%) lactic acid solution, consisted of a centrifu-
gal pump (Jostra rotaflow, Maquet, Hechingen, Germany),
a gas trap, a polysulphone membrane dialyzer (F8HPS,
Fresenius, Bad-Homburg, Germany) and 1/4 to
3/16 inch
inner-diameter tubing. No membrane lung was placed in
the extracorporeal circuit. The outlet port of the dialyzer
was connected to the inlet port to create a closed system
with the dialysate flowing countercurrent to blood flow.
The experimental setup is outlined in Figure 1. The
extracorporeal blood flow was set to 250 ml/minute and
the dialysate flow at 300 ml/minute. A target activated
clotting time (Hemocron Jr. Signature, ITC, Edison, NJ,
USA) value of 250 to 300 sec was maintained by titrating
a continuous infusion of unfractioned heparin.
During the experiment, the tidal volume was adjusted
in order to maintain an arterial PCO2 of 50 mmHg,
which is a physiologic value for both our animal model
and the chronic hypercapnic patients and corresponds
to a nearly neutral pH due to the high bicarbonate con-
tent of their blood. The inspiratory oxygen fraction was
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external physical methods. An intravenous infusion of a
rapid-acting insulin analog was titrated to keep blood
glucose levels constant (target = 100 mg/dl). At the end
of the experiment all the pigs were sacrificed with a
bolus injection of KCl (40 mEq) in the central venous
line.
Study design
The experiment consisted of two steps, lasting four
hours each, which differed only for the caloric source
provided:
– Glucose step: 97 kcal/h were administered, through
the central venous catheter, as a 50% glucose
solution (52 ml/h)
– Lactic Acid step: 48.5 kcal/h were administered
(34 ml/h) as a L-(+)-Lactic acid solution approxi-
mately 40% in H2O (Sigma-Aldrich Corp. St. Louis,
MO, USA) into the gas trap of the recirculating di-
alysate [14], 48.5 kcal/h as 50% glucose solution
(26 ml/h) were infused through the central venous
catheter), for a total caloric load of 97 Kcal/h. The
infused lactic acid amounted, therefore, to 2.5 mEq/
minute.
These two steps, always performed in a preset se-
quence (Glucose followed by Lactic Acid) were repeated
three times with a two-hour interval following the Lactic
Acid step to allow a complete clearance of the infused
lactate (Figure 2).
The total caloric intake during the whole study period
was approximately 2,330 kcal/day, consistent with the
estimated basal metabolic rate of anesthetized and cura-
rized swine weighing approximately 45 kg [18].
Every hour (except during the two-hour interval after
discontinuation of lactic acid infusion) we recorded: total
CO2 production (VCO2), body temperature, arterial blood
gases, blood glucose and arterial lactate level, hemodynamic
parameters (heart rate, systemic arterial pressure, centralFigure 2 Schematic representation of the experiment timeline.venous pressure) and ventilatory parameters (tidal volume,
respiratory rate, minute ventilation, airway pressures). All
the blood gas analyses were performed with the ABL 800
FLEX (Radiometer, A. De Mori, Milano, Italy) which is
equipped for the automatic determination of pH, blood
gases, oxymetry, electrolytes, glucose and lactate. Fully au-
tomated quality controls are carried out; every four hours a
manual calibration was performed. The ABL 800 measures
the lactate concentration in the plasma. We calculated the
ventilation of the dead space (VD) according to the stand-
ard equation: VD =VE * (PaCO2-PeCO2/PaCO2). PeCO2 =
partial pressure of expired mixed CO2. Alveolar ventilation
(VA) was calculated as follows: VA =VE - VD.
Total CO2 production (VCO2) was calculated as the
product of expired CO2 concentration and minute venti-
lation (VE). The expired CO2 concentration was mea-
sured through an infrared CO2 analyzer (WMA-4, GMR
Strumenti SAS, Florence, Italy) sampling at 400 ml/mi-
nute from a 20-liter mixing box connected to the ex-
haled gas exhaust port of the ventilator. VE was read
from the ventilator, which was calibrated against a
pneumotachograph (MLT300L, ADInstruments, Sydney,
QLD, Australia), whose accuracy was regularly checked
with a calibrated syringe.Statistical analysis
Statistical analysis was performed using the SigmaPlot
11.2 statistical software (Systat Software Inc., Chicago,
IL, USA). Data are expressed as means ± standard devia-
tions. To compare data of Glucose steps versus Lactic
Acid steps a paired Student t-test was used. A paired-t
analysis was performed to increase the statistical power,
eliminating the confounding factor of the between-pig
variation; actually a much larger sample would have
been required to reject the null hypothesis without a
paired analysis. The Shapiro-Wilk test was used to assess
normality of the samples. A two-way ANOVA was per-
formed to assess whether the time factor had an impact
on VCO2 during the different steps.
Table 1 Main hemodynamic and respiratory parameters
Glucose Lactic acid P
Heart rate, bpm 91 ± 15 87 ± 18 P = 0.19
MAP, mmHg 74 ± 14 71 ± 12 P = 0.12
CVP, mmHg 10 ± 3 10 ± 4 P = 0.32
TV, ml 489 ± 52 513 ± 50 P <0.05
RR, breaths per minute 17.2 ± 1.2 17.2 ± 1.2 P = 0.32
bpm, beats per minute; CVP, Central Venous Pressure; MAP, Mean Arterial
Pressure; RR, Respiratory Rate; TV, Tidal Volume. Mean ± standard deviation of
data collected at first, second and fourth hour of each step.
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A total of 16 two-step sequences (Glucose - Lactic Acid),
were conducted on six animals. No complications re-
lated to lactic acid infusion were reported. In two pigs
the study was interrupted before the third two-step se-
quence, in one case due to abrupt clotting of an extra-
corporeal cannula and in the other case due to severe
hemodynamic instability.
The average total CO2 production was 269 ± 22 and
282 ± 19 ml/minute, respectively, during Glucose and
Lactic Acid infusion (P <0.05). The increase in VCO2
during the Lactic Acid step was 4.8%. This difference in
VCO2, though quantitatively small, was, however, statis-
tically significant at the first, third and fourth hours of
each step (see Figure 3), but not at the 2nd. The time fac-
tor did not affect VCO2 (P = 1.00), which remained
stable over time during both the Glucose and Lactic
Acid steps.
Arterial lactate was higher (2.6 ± 0.6 vs. 0.4 ± 0.2 mmol/l,
P <0.05), arterial pH was lower (7.422 ± 0.03 vs. 7.445 ±
0.02, P <0.05) and HCO3
- was lower (32.2 ± 2.3 vs. 33.9 ±
1.7 mmol/L, P <0.05) during the Lactic Acid steps. Arterial
PCO2 (50.1 ± 1.4 vs. 50.3 ± 1.5 mmHg, P = 0.54) and arter-
ial glucose (107 ± 15 and 104 ± 13 mg/dl, P = 0.25) were
kept constant; as was the amount of insulin needed to
maintain target blood glucose (1.2 ± 0.8 and 1.3 ± 1 U/h
during Lactic Acid and Glucose, respectively, P = 0.61). Ar-
terial PO2 was 175 ± 30 mmHg during Lactic Acid and
167 ± 34 during Glucose (P = 0.22).
Minute ventilation (8.7 ± 1.2 vs. 8.3 ± 1.2 L/minute,
P <0.05) and alveolar ventilation (4 ± 0.3 vs. 3.8 ±
0.3 L/minute, P <0.05) were slightly (barely 5%) but
significantly higher during Lactic Acid steps.
Body temperature was not different during Lactic Acid
(38.0 ± 0.1°C) or Glucose (38.1 ± 0.1°C), P = 0.06. At all
sample times all hemodynamic and respiratory parame-
ters were comparable in both groups, except for a smallFigure 3 VCO2 during Glucose and Lactic Acid steps over
time. *: P <0.05 versus the glucose step at the same time.increase in tidal volume which was required to compen-
sate for the VCO2 rise (see Table 1).
Discussion
In the present study, we evaluated the VCO2 changes in
anesthetized pigs associated with lactic acid infusion.
While maintaining a constant caloric intake, replace-
ment of 50% of the caloric input with lactic acid, corre-
sponding to an infusion of 2.5 m Eq/minute, caused an
increase in total CO2 production of less than 5% (13 ml/
minute).
This clinically small but statistically significant differ-
ence in total CO2 production may be due to several
causes. First, a small increase in total VCO2 during lactic
acid infusion is expected since the complete oxidation of
lactate load produces 3.6% more CO2 than an amount of
glucose of equal caloric content. Therefore, since in the
present study lactic acid infusion provided 50% of the
total caloric intake, a VCO2 increase of about 1.8% was
expected. A variable proportion of the infused lactic acid
may enter gluconeogenesis, and then possibly be stored
as glycogen. The net result of this process will also cause
a net increase in VCO2.
Another factor contributing to the VCO2 increase may
result from the conversion of bicarbonate ions into CO2,
caused by the increased systemic steady state levels of
lactate and the resulting very mild metabolic acidosis.
Indeed, although lactate levels remained lower than
3 mEq/l, a small reduction in arterial pH (of 0.023 pH
units) was recorded. Such a systemic pH drop, promot-
ing the «shift» of bicarbonate towards dissolved CO2,
may have caused a transient increase in VCO2, despite a
stable metabolic CO2 production. Failure to reach a
steady state condition during lactic acid infusion might
have contributed to the slight increase in VCO2. Overall,
during lactic acid infusion, in order to maintain a con-
stant arterial PCO2, a small increase in alveolar ventila-
tion (5%) was required.
The infusion of lactic acid at the inlet of a membrane
lung, by shifting the equilibrium towards the dissolved
form of carbon dioxide, determines a significant increase
of extracorporeal CO2 removal [12]. We have previously
shown, in a similar animal model [14], that an infusion
Table 2 CO2 production from total oxidation of different
substrates to produce 1 Kcal
Substrate Kcal Mmol of
substrate
CO2 production
(mmol)
CO2 production (ml)
Glucose 1 1.48 8.9 199
Lactate 1 3.08 9.25 207
Acetate 1 4.93 9.85 220
Citrate 1 2.12 12.73 285
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in the present study) at the inlet of a pediatric artificial
lung (extracorporeal blood flow 0.25 L/minute), could
increase extracorporeal CO2 removal by approximately
40 to 45 ml/minute (60 ± 9 vs. 101 ± 16 ml/minute, with-
out and with lactic acid infusion, respectively), while the
PaCO2 was maintained constant at 50 mmHg as in the
current study. In that experiment we did not maintain a
constant caloric intake, (caloric input increased from 43
to 90 Kcal/h when lactic acid was infused), hence, the
total VCO2 was not evaluated.
In the current study, at variance, we kept the caloric in-
put constant and we observed that lactic acid infusion
slightly increases the total CO2 production (13 ml/minute
with our experimental setting). We may, therefore, specu-
late that regional extracorporeal blood acidification at the
inlet of the membrane lung may allow a substantial de-
crease in the patient’s ventilatory needs; actually, despite
increasing the total CO2 production (13 ml/minute in-
crease), it produces a significantly higher increase in
extracorporeal CO2 removal (40 to 45 ml/minute in-
crease). This assumption may be true only if, during
lactic acid infusion, the total caloric intake is main-
tained constant.
The caloric input (around 2,330 kcal/day) applied in
the present study, was based on literature and prelim-
inary data [14,18]. The infusion of 2.5 mEq/minute of
lactic acid (approximately 1,150 Kcal/day), represent-
ing around 50% of the daily energy requirement of
our model, would provide a conspicuous fraction of
the daily caloric needs of an ICU patient and, there-
fore, it should always be included in the energy
balance.
The actual impact of lactic acid infusion, as part of an
extracorporeal CO2 removal technique, on the nutri-
tional balance is still to be determined. Lactate enters
the glucose metabolism pathway after conversion to
pyruvate; if a patient’s total caloric input is kept con-
stant, we can assume that this pyruvate may follow the
same metabolic pathway as the pyruvate produced from
glucose metabolism. Furthermore, the insulin infusion
rate required during the Glucose and Lactic acid steps
to maintain a constant blood glucose concentration was
similar and very low; hence, it is unlikely that insulin in-
fusion may have altered the balance between glucose
storage and glucose oxidation.
The choice of lactic acid to achieve blood acidifica-
tion has several advantages: it is not toxic [17], it has
a very fast metabolism and point-of-care testing of
lactate is available in most ICUs. In our previous
study we also demonstrated that a 48-hour lactic acid
infusion, performed through an extracorporeal dialysis
circuit, is safe and does not lead to any injury of red
blood cells and major organs [14]. Blood acidificationmay be achieved by infusion of other metabolizable
acids, such as citric or acetic acid; however, their an-
ions are difficult to measure in the clinical setting.
Moreover, their clearance is less predictable than that
of lactate, at least for citric acid [19]. Furthermore, oxi-
dation of equal caloric amounts of these acids produces
more CO2 than lactic acid (see Table 2).
An alternative choice may be the utilization of non-
metabolizable acids (for example, hydrochloric acid),
which do not provide calories; however, their usage re-
quires an extracorporeal removal of the infused anions
which may significantly increase the complexity of the
extracorporeal system [20,21].
Some limitations of the present study deserve to be
discussed. First, our animal model may present some dif-
ferences from humans: in a growing pig, even if anesthe-
tized and paralyzed, the basal energy requirement and
VCO2 per unit weight are far greater than those of an
adult man [22]. Moreover, we cannot exclude the fact
that different results would have derived from a critically
ill animal model. Second, in our model, the arterial pH
and bicarbonate ion concentrations are elevated, and
may not closely represent the critical patients, even
though the bicarbonate levels may be comparable to the
one of chronic hypercapnic patients. Third, we did not
investigate the metabolic pathway of infused lactate,
which would have required the application of specific
techniques (for example, use of isotopic carbon-labeled
glucose or lactate) that are beyond the scope of the
present investigation.Conclusions
Administration of 50% of the total caloric input with an
infusion of lactic acid (2.5 mEq/minute) only marginally
increased (less than 5%) the total CO2 production com-
pared to an equal caloric load provided entirely by infu-
sion of a 50% glucose solution. Since an equal rate of
acidification, as shown in a previous study, increased the
membrane lung removal by at least 50 ml/minute, we
may speculate that blood acidification at the inlet of a
membrane lung could be a promising technique to re-
duce the ventilatory needs.
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 Infusion of lactic acid slightly increases the total
CO2 production compared to an isocaloric infusion
of glucose.
 An extracorporeal CO2 removal technique based on
blood acidification with lactic acid infusion could be
a promising technique to reduce the ventilatory
needs, if the total caloric intake is kept constant.
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